YEM Search

搜索结果

ABHD12

靶点ID:TCMBANKGE004498

靶点别名:ABHD12A; BEM46L2; C20orf22; PHARC; dJ965G21.2; hABHD12

靶点描述:abhydrolase domain containing 12, lysophospholipase

染色体:20

染色体位置:20p11.21

靶点类型:protein-coding

HERB_ID:HBTAR006981

HGNC_Link:15868

OMIM_Link:613599

Ensembl_Link:ENSG00000100997

靶点对应的植物

ID	拉丁名	药名	药用植物名	功能与主治	来源	药用部位	使用民族

靶点对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN020708	Ethyl ferulate	ethyl (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; ethyl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; Ethyl-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; Ethyl (2E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoate; ethyl 3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoate; AIDS097067; AIDS-097067; Ethyl 4-hydroxy-3-methoxycinnamate; ethyl (E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoate; 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid ethyl ester; Ferulic acid, ethyl ester; 2-Propenoic acid, 3-(4-hydroxy-3-methoxyphenyl)-, ethyl ester; Cinnamic acid, 4-hydroxy-3-methoxy-, ethyl ester; 4046-02-0; 320617_ALDRICH; (E)-3-(4-hydroxy-3-methoxy-phenyl)acrylic acid ethyl ester; 3-(4-hydroxy-3-methoxy-phenyl)acrylic acid ethyl ester; Ferulic acid ethyl ester; NSC14879; AI3-23714; ethylferulate; EINECS 223-745-5; ZINC00160496; Ferulic acid ethylester; Ethyl 4'-hydroxy-3'-methoxycinnamate; (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid ethyl ester	C12H14O4	222.24	CCOC(=O)C=CC1=CC(=C(C=C1)O)OC
TCMBANKIN058114	trans-caffeic acid	3-(3,4-dihydroxy-phenyl)-acrylic acid; caffeic acid; Caffeate; Lopac-C-0625; 71693-97-5; DivK1c_006624; KBio2_007302; (Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; NCGC00015206-02; CAS-3331-39-5; 60020_FLUKA; AI3-63211; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid polymer; (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; NSC623438; 4-(2'-Carboxyvinyl)-1,2-dihydroxybenzene; KBio2_004734; (2Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; CHEMBL1320034; AIDS-002287; AIDS002287; 501-16-6; CHEBI:36281; Prestwick1_000902; KBio1_001568; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid; AKOS000273846; OR1165; SMR000058214; Spectrum2_001612; 3,4-dihydroxycinnamate; (Z)-3-(3,4-dihydroxyphenyl)acrylic acid; Caffeicacid; KOP; AC1NO658; CCRIS 847; Caffeic acid dehydrogenation homopolymer; SPECTRUM1503987; Spectrum4_001694; SCHEMBL3682144; NCGC00017364-01; NCGC00022654-08; 4-(2-Carboxyethenyl)-1,2-dihydroxybenzene; 78734C5A-1281-44D4-B8A0-A3188AD437E3; cis-Caffeic acid; 3-(3,4-dihydroxyphenyl)acrylic acid; Cinnamic acid, 3,4-dihydroxy-; KBioGR_001988; 3,4-Dihydroxybenzeneacrylic acid; 3,4-dihydroxycinnamic acid; trans-caffeic acid; AIDS-026339; NCGC00015206-01; HSDB 7088; ZINC4482687; (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; 3-(3,4-dihydroxyphenyl)prop-2-enoate; Isocaffeic acid; SBB006475; InChI=1/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/b4-2; NCGC00017364-02; EU-0100208; C01197; MolPort-001-759-162; KBioSS_002166; Caffeic acid pure; caffeic acid ; trans-Caffeate; (2E)-3-(3,4-dihydroxyphenyl)acrylic acid; NSC 57197; (2E)-3-(3,4-Dihydroxyphenyl)-2-propenoic acid; Spectrum_001686; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, (E)-; KBio2_002166; Caffeic acid, cis-; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-; 3,4-Dihydroxybenzeneacrylate; 3-(3,4-Dihydroxy phenyl)-2-propenoic acid; 4361-87-9; 3,4-Dihydroxy-trans-cinnamate; caffeicacid; AR-360/40806927; EINECS 206-361-2; 60018_FLUKA; Caffeic acid polymer; (E)-3-(3,4-dihydroxyphenyl)acrylic acid; NCGC00022654-04; ZX-AL002121; C0625_SIGMA; SDCCGMLS-0002982.P003; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid, homopolymer; SPBio_001643; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)- (9CI); NCGC00017364-03; 3-(3,4-dihydroxyphenyl)prop-2-enoic acid; AC1LU7RL; SPBio_002943; CHEBI:16433; AIDS026339; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, homopolymer; CHEBI:17395; TNP00311; SpecPlus_000528; Prestwick0_000902; MLS000069738; 3,4-dihydroxy-cinnamic acid; 3-(3,4-Dihydroxyphenyl)propenoic acid; NCI60_004400; NSC57197; Caffeic; Lopac-C-0625; NCGC00015206-01; Caffeic acid; cis-Caffeic acid; NCGC00017364-01; (Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; C01481; 331-39-5; NCGC00015206-02; CAS-3331-39-5; 3,4-Dihydroxycinnamic acid; CHEBI:17395; (2Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; TNP00311; (Z)-3-(3,4-dihydroxyphenyl)acrylic acid; Caffeate; 1- coffee acid	C9H8O4	180.16 g/mol	C1=CC(=C(C=C1C=CC(=O)O)O)O

靶点对应的疾病

疾病ID	疾病名	MeSH名	HPO名	UMLS名	疾病类型

TCMBANKDI000490		Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Nervous System Diseases	-	Disease or Syndrome	disease
TCMBANKDI000865		Pathological Conditions, Signs and Symptoms; Nervous System Diseases	Abnormality of the nervous system	Sign or Symptom	phenotype
TCMBANKDI001683		-	Abnormality of the nervous system	Finding	phenotype
TCMBANKDI001889		Pathological Conditions, Signs and Symptoms; Nervous System Diseases	Abnormality of the nervous system	Finding	phenotype
TCMBANKDI002718		-	-	Finding	phenotype
TCMBANKDI004690		Pathological Conditions, Signs and Symptoms; Nervous System Diseases	Abnormality of the nervous system	Finding	phenotype
TCMBANKDI005599		-	-	Disease or Syndrome	disease
TCMBANKDI007228		-	-	Finding	phenotype
TCMBANKDI007343		Pathological Conditions, Signs and Symptoms; Nervous System Diseases	-	Finding	phenotype
TCMBANKDI011700		Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Musculoskeletal Diseases	Abnormality of limbs	Congenital Abnormality	disease
TCMBANKDI017965		Pathological Conditions, Signs and Symptoms; Nervous System Diseases	Abnormality of the nervous system	Finding	phenotype
TCMBANKDI018931		-	-	Finding	phenotype
TCMBANKDI019267		Pathological Conditions, Signs and Symptoms; Nervous System Diseases	Abnormality of the nervous system	Sign or Symptom	phenotype
TCMBANKDI019669		Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases	Abnormality of the eye	Acquired Abnormality	disease
TCMBANKDI022394		-	-	Laboratory Procedure	phenotype
TCMBANKDI026106		Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases	-	Congenital Abnormality	disease
TCMBANKDI028908		Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases	Abnormality of the eye	Disease or Syndrome	phenotype
TCMBANKDI030866		Eye Diseases	Abnormality of the eye	Anatomical Abnormality	disease